Journal of Clinical Oncology
Articles in this Issue
Co-creating patient partnership within a national cancer trials network: Experience from Cancer Trials Ireland in partnership with the Irish Cancer Society.
11061 Background: Structured patient partnership is increasingly recognised in oncology research, yet less is known about...
Understanding palliative care gaps in young adult ovarian cancer: A population-based study of 37,880 hospitalizations.
5557 Background: Palliative care (PalC) improves both quality of life and survival compared to usual care. Despite this, s...
Effects of prophylactic fibrin glue on post-gastric ESD bleeding in gastric neoplasm: A meta-analysis of randomized controlled trials.
e16148 Background: Post-procedural bleeding remains a significant complication following gastric endoscopic submucosal dis...
<i>CCND1</i> amplification and breast cancer–specific survival in estrogen receptor–positive, HER2-negative disease.
e12723 Background: Amplification of Cyclin D1 ( CCND1 ) is common in estrogen rece...
Outcomes following surgery versus non-surgical management for gallbladder cancer patients presenting with jaundice: A systematic review and meta-analysis.
e16230 Background: Gallbladder cancer (GBC) presenting with obstructive jaundice typically indicates advanced disease and...
National trends for cervical cancer–related mortality rates from 1999-2020: A National Inpatient Sample–based analysis.
e17517 Background: Cervical cancer is a malignant epithelial tumor that forms in the cervix of the uterus, caused primaril...
Distinct immunologic vs progenitor landscapes in myeloid leukemia recurrence: Adaptive immune persistence in pediatrics vs niche exhaustion in adults.
10021 Background: Recurrent myeloid leukemia remains a therapeutic challenge with distinct clinical trajectories across ag...
A National Cancer Database analysis of hepatoid adenocarcinoma: Epidemiology, socioeconomic, and clinical factors.
e20767 Background: Hepatoid adenocarcinoma (HAC) is a rare extrahepatic neoplasm that displays histologic similarity to he...
Influence of a vertically integrated care system on mortality risks in insured patients by socio-economic status.
e13560 Background: Vertically integrated health care delivery systems may help reduce disparities in cancer outcomes due t...
Second-line cetuximab monotherapy following PD-1 inhibitor treatments in patients with recurrent/metastatic head and neck carcinoma.
6055 Background: PD-1 inhibitors, alone or in combination with chemotherapy, are standard first-line therapy for recurrent...
Characterization and clinical impact of temozolomide-induced hepatotoxicity in <i>IDH</i> -wild type glioblastoma: A comprehensive analysis of injury patterns, CTCAE grade transitions, and survival outcomes.
e14075 Background: Temozolomide (TMZ) is the cornerstone of glioblastoma (GBM) treatment but is associated with potential...
Inpatient palliative care utilization and outcomes among decedent patients with metastatic cancer in the U.S.
11119 Background: Palliative care (PC) is a key component of high quality cancer care, especially at the end of life. Howe...
Demographics and trends of acute myeloid leukemia among young adults in the United States and Puerto Rico, 1999-2021.
e18502 Background: We assessed racial and sex-related trends in deaths from Acute Myeloid Leukemia (AML) among US and Puer...
Study of the cytostatic effect of a new compound of the tropolon series on primary cultures of glioma cells.
e14056 Background: Brain tumors present a genuine challenge for medicine due to their anatomical features, high resistance...
Early neutrophil incompetence following allogeneic stem cell transplant.
6565 Background: Neutrophils are key immune effector cells against fungal pathogens such as Candida al...
Clinical outcomes with brexucabtagene autoleucel in refractory mantle cell lymphoma: A systematic review and single-arm meta-analysis with contextual comparison to lisocabtagene maraleucel.
e19010 Background: Chimeric antigen receptor T-cell (CAR-T) therapy has improved outcomes for patients with refractory man...
Temporal trends in cardiovascular mortality among ovarian cancer patients in the United States: A 22-year analysis of United States mortality data by age, race, and geographic region, 1999-2020.
e17584 Background: Cardiovascular disease (CVD) represents a significant competing cause of death among ovarian cancer sur...
Same day/next day cancer care program: An early access program for patients with aggressive malignancies.
11095 Background: Rapid referral of patients with suspected malignant disease to an oncology specialist is associated with...
<i>HER2</i> mutations in advanced NSCLC: Prevalence, mutational context, and clinical outcomes from an Australian clinico-genomic database.
e20673 Background: ERBB2 mutations ( HER2 mut) are an emerging...
Evaluating performance of an AI-based recurrence score in early breast cancer patients treated with chemoendocrine therapy: A secondary analysis of the UNIRAD trial.
550 Background: Patients with node-positive HR+/HER2- early breast cancer are at high risk for relapse within 5 years of d...
Prediction of hematotoxicity using CT-derived body composition in rectal cancer patients receiving immunotherapy-based total neoadjuvant therapy.
3599 Background: Immunotherapy-based total neoadjuvant therapy (iTNT) is a promising strategy to enhance complete response...
Empowering educators: An international virtual mentorship program for hematology/oncology medical educators.
9036 Background: Mentorship is a cornerstone of physician career development, linked to improved well-being, job satisfact...
Long-term efficacy and safety of first-line (1L) nivolumab plus relatlimab (NIVO + RELA) versus NIVO plus ipilimumab (NIVO + IPI) in advanced melanoma: An updated indirect treatment comparison (ITC) with 5-year follow-up data.
9530 Background: An ITC comparing NIVO + RELA and NIVO + IPI, approved dual immunotherapy treatment options for patients (...
AndroMETa-Lung-713: A phase 2/3 study of telisotuzumab adizutecan (ABBV-400, Temab-A) vs standard of care (SOC) in patients with epidermal growth factor receptor ( <i>EGFR</i> )–mutated non–small cell lung cancer (NSCLC).
TPS8661 Background: Patients with advanced EGFR -mutated NSCLC routinely receive t...
Exosomal miRNA signatures as predictors of response to neoadjuvant FOLFIRINOX and GEM/nab-paclitaxel in resectable pancreatic cancer: The PRECEPT study.
4223 Background: Neoadjuvant chemotherapy (NAC) with FOLFIRINOX or gemcitabine plus nab-paclitaxel (GEM/nab-PTX) is widely...